Tuesday, 28 September 2021 02:29 GMT

Cannabidiol (CBD) Market Size to Reach USD 15.15 Billion in 2028 With CAGR of 22.6% | Reports and Data


(MENAFN- iCrowdNewsWire) Rising awareness about the therapeutic benefits of cannabidiol and growing medical uses of CBD are the major market growth drivers

The global cannabidiol (CBD) market  size is expected to reach USD 15.15 billion in 2028 and register a revenue CAGR of 22.6% over the forecast period, according to the latest report by Reports and Data. The most important factors driving market revenue growth are rising awareness about the medicinal uses of CBD and increasing government approvals for cannabidiol use in numerous consumer products. Increasing research & development activities related CBD, increasing incorporation of CBD in a wide range of food and beverage products, rising health consciousness among consumers, and growing demand for cannabis in the pharmaceutical and cosmetics & personal care industries are other major factors expected to support market growth during the forecast period.

Get a sample of the report @  

The global Cannabidiol (CBD) market is expected to register significant growth throughout the forecast period. The pharmaceutical & healthcare sector has register significant revenue growth over the recent past. Technological advancements in the healthcare and medical sector, availability of latest tools and techniques, increasing investments in the healthcare sector and improving healthcare infrastructure are key factors boosting market growth. In addition, rising funds by several public and private sectors, high adoption of POC diagnosis and home care settings, is further fueling market growth.

The current pandemic has been very challenging for all industries including the healthcare and pharma sector. Shortage of medicines, vaccines and others healthcare facilities is expected to open lucrative growth opportunities for market players in going ahead.

Competitive Landscape:

The report offers detailed information about recent activities by market players, their market position, financial status, global standing, services and product portfolio along with license agreement. These key players are adopting various strategies such as partnerships, collaborations, merger and acquisitions, and joint ventures to gain robust footing in the market. These players are also investing in research and development activities to come up with enhanced materials and products.

Some Key Highlights from the Report:

Based on product type, the oils segment is expected to hold the largest revenue share in the global cannabidiol (CBD) market over the forecast period, primarily owing to growing demand for CBD-based oils due to numerous advantages, most notably, pain relief. CBD-infused oils are known to relieve pain, inflammation, stress, and mental problems such as depression and anxiety. Increasing prevalence of chronic pain, mostly among the geriatric population, and growing preference for CBD oils over opioids due to minimal or no side-effects are other key factors boosting growth of this segment.

Based on source, the hemp segment accounted for the highest revenue share of around 60% in the global market in 2020. Increasing pharmaceutical uses of cannabidiol, growing consumer awareness of the therapeutic benefits including anti-aging, anti-inflammatory, and antioxidant properties of hemp-derived CBD, legalization of medicinal cannabis, and growing use of CBD in nutraceuticals and cosmeceuticals are major factors propelling the growth of this segment.

The medical segment is expected to dominate other application segments in the market in terms revenue generation over the forecast period. Growth of this segment is majorly attributed to increasing research studies on the medicinal uses of CBD, growing use in pain relief medications, rising awareness about the medical benefits of cannabidiol, and increased spending on CBD pharmaceutical products.

North America was the most dominant regional market in the global cannabidiol (CBD) market in 2020, with the highest revenue share of over 40%. Increasing personal and medical uses of marijuana and its derivatives in the region, growing awareness about the health benefits of cannabis, increasing public acceptance of CBD, and legalization of cannabidiol and its use in various consumer products including food & beverages and nutraceuticals are key factors contributing to the North America revenue growth. Moreover, revenue growth in the regional market is further driven by the presence of leading pharmaceutical retailers – mostly in the U.S., including CVS Health, Walgreens, and Rite Aid – selling a wide array of cannabis-based products.

Leading players in the global cannabidiol (CBD) market include Folium Biosciences LLC, Elixinol Wellness Limited, Medterra, CV Sciences, Inc., Aurora Cannabis Inc., Medical Marijuana Inc., Isodiol International Inc., Cannoid, LLC, PharmaHemp CBD Izdelki, and ENDOCA.

Request a discount on the report @ 

For the purpose of this report, the global cannabidiol (CBD) market is segmented on the basis of product type, source, application, distribution channel, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

  • Tinctures
  • Isolates
  • Pills & Capsules
  • Oils
  • Vape Oil
  • Ointment Roll-on
  • Transdermal Patches
  • Suppository
  • Others

Source Outlook (Revenue, USD Billion; 2018-2028)

  • Hemp
  • Marijuana

Application Outlook (Revenue, USD Billion; 2018-2028)

  • Personal Use
  • Medical
    • Cancer
    • Chronic Pain
    • Mental Disorders
    • Others
  • Food & Beverages
  • Cosmetics & Personal Care
  • Nutraceuticals
  • Others

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

  • Offline Channels
  • Online Channels

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Request a customization of the report @ 

Thank you for reading the research report on global Cannabidiol (CBD) market. Kindly contact us to know more about the customization feature and our team will offer the best suited report as per your requirement.

Read More Reports:-         

Implantable Ports Market @

Trauma Devices Market @

Surgical Lights Market @

Pain Management Devices Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Related Post  Antibody Services Market Share, Size, Global Driving Factors by Manufacturers, Growth Opportunities, Regions, Type and Application, Revenue Market Forecast to 2028  Automated Immunoassay Analyzers Market by Type, Share, Growth, Trends and Forecast To 2028 by Top Players BioRad, Siemens Healthcare, Roche Diagnostics, Ortho Clinical Diagnostics  Arthroscopic Devices Market Size, Company Revenue Share, Key Drivers & Trend Analysis 2026  Trade Credit Insurance Market Size, Opportunities, Key Growth Factors, Revenue Analysis, For 2020–2027  Wheat Protein Market Revenue Share | Growth Factors, Trends, Analysis & Forecast, 2027

MENAFN15092021003318003403ID1102804416


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.